4//SEC Filing
Owens Daniel E. 4
Accession 0001209191-22-057740
CIK 0001630627other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 8:00 PM ET
Size
9.4 KB
Accession
0001209191-22-057740
Insider Transaction Report
Form 4
Owens Daniel E.
Chief HR Officer
Transactions
- Sale
Common Stock
2022-11-15$20.38/sh−6,250$127,371→ 10,700 total - Exercise/Conversion
Common Stock
2022-11-15$7.03/sh+6,250$43,925→ 16,950 total - Exercise/Conversion
Stock Option Right to Buy
2022-11-15−6,250→ 186,375 totalExercise: $7.03Exp: 2031-02-02→ Common Stock (6,250 underlying)
Footnotes (4)
- [F1]The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Includes 6,700 RSUs.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.3432 to $20.4338 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001858105
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 8:00 PM ET
- Size
- 9.4 KB